Christian M - Search Results

1

Dose-intense taxol: high response rate in patients with platinum-resistant recurrent ovarian cancer.

Kohn EC, Sarosy G, Bicher A, Link C, Christian M, Steinberg SM, Rothenberg M, Adamo DO, Davis P, Ognibene FP, et al. Kohn EC, et al. Among authors: christian m. J Natl Cancer Inst. 1994 Jan 5;86(1):18-24. doi: 10.1093/jnci/86.1.18. J Natl Cancer Inst. 1994. PMID: 7505830 Clinical Trial.

2

The absence of cumulative bone marrow toxicity in patients with recurrent adenocarcinoma of the ovary receiving dose-intense taxol and granulocyte colony stimulating factor.

Bicher A, Kohn E, Sarosy G, Davis P, Adamo DO, Jacob J, Christian M, Reed E. Bicher A, et al. Among authors: christian m. Anticancer Drugs. 1993 Apr;4(2):141-8. doi: 10.1097/00001813-199304000-00003. Anticancer Drugs. 1993. PMID: 7683933

3

Clinical investigation of a cytostatic calcium influx inhibitor in patients with refractory cancers.

Kohn EC, Reed E, Sarosy G, Christian M, Link CJ, Cole K, Figg WD, Davis PA, Jacob J, Goldspiel B, Liotta LA. Kohn EC, et al. Among authors: christian m. Cancer Res. 1996 Feb 1;56(3):569-73. Cancer Res. 1996. PMID: 8564973 Clinical Trial.

4

A phase I study of paclitaxel and cyclophosphamide in recurrent adenocarcinoma of the ovary.

Reed E, Sarosy G, Kohn E, Christian M, Link CJ Jr, Goldspiel B, Davis P, Jacob J, Maher M. Reed E, et al. Among authors: christian m. Gynecol Oncol. 1996 Jun;61(3):349-53. doi: 10.1006/gyno.1996.0155. Gynecol Oncol. 1996. PMID: 8641614 Clinical Trial.

5

A phase I/II study of dose-intense paclitaxel with cisplatin and cyclophosphamide as initial therapy of poor-prognosis advanced-stage epithelial ovarian cancer.

Kohn EC, Sarosy GA, Davis P, Christian M, Link CE, Ognibene FP, Sindelar WF, Jacob J, Steinberg SM, Premkumar A, Reed E. Kohn EC, et al. Among authors: christian m. Gynecol Oncol. 1996 Aug;62(2):181-91. doi: 10.1006/gyno.1996.0213. Gynecol Oncol. 1996. PMID: 8751547 Clinical Trial.

6

Cutaneous manifestations of Taxol therapy.

Link CJ Jr, Sarosy GA, Kohn EC, Christian MC, Davis P, Adamo DO, Reed E. Link CJ Jr, et al. Among authors: christian mc. Invest New Drugs. 1995;13(3):261-3. doi: 10.1007/BF00873811. Invest New Drugs. 1995. PMID: 8729957

7

Pharmacokinetics of elemental platinum (ultrafiltrate and total) after a thirty minute intravenous infusion of ormaplatin.

Figg WD, Christian MC, Lush R, Link CJ, Davis P, Kohn E, Sarosy G, Rothenberg ML, Weiss RB, Ryan N, Jacobs J, Reed E. Figg WD, et al. Among authors: christian mc. Biopharm Drug Dispos. 1997 May;18(4):347-59. doi: 10.1002/(sici)1099-081x(199705)18:4<347::aid-bdd23>3.0.co;2-o. Biopharm Drug Dispos. 1997. PMID: 9158882 Clinical Trial.

8

Clinical development of Taxol.

Arbuck SG, Christian MC, Fisherman JS, Cazenave LA, Sarosy G, Suffness M, Adams J, Canetta R, Cole KE, Friedman MA. Arbuck SG, et al. Among authors: christian mc. J Natl Cancer Inst Monogr. 1993;(15):11-24. J Natl Cancer Inst Monogr. 1993. PMID: 7912517 Review.

9

Flexible granulocyte colony-stimulating factor dosing in ovarian cancer patients who receive dose-intense taxol therapy.

Link CJ Jr, Bicher A, Kohn EC, Christian MC, Davis PA, Adamo DO, Reed E, Sarosy GA. Link CJ Jr, et al. Among authors: christian mc. Blood. 1994 Mar 1;83(5):1188-92. Blood. 1994. PMID: 7509652 Free article. Clinical Trial.

10

A reassessment of cardiac toxicity associated with Taxol.

Arbuck SG, Strauss H, Rowinsky E, Christian M, Suffness M, Adams J, Oakes M, McGuire W, Reed E, Gibbs H, et al. Arbuck SG, et al. Among authors: christian m. J Natl Cancer Inst Monogr. 1993;(15):117-30. J Natl Cancer Inst Monogr. 1993. PMID: 7912518 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

710 results

Search Page